These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16262896)

  • 21. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
    Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
    Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
    Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
    Du Z; Hou S
    J Urol; 2003 Nov; 170(5):2000-3. PubMed ID: 14532841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
    Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
    Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endostatin induces autophagic cell death in EAhy926 human endothelial cells.
    Chau YP; Lin SY; Chen JH; Tai MH
    Histol Histopathol; 2003 Jul; 18(3):715-26. PubMed ID: 12792883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment.
    Alahuhta I; Aikio M; Väyrynen O; Nurmenniemi S; Suojanen J; Teppo S; Pihlajaniemi T; Heljasvaara R; Salo T; Nyberg P
    Exp Cell Res; 2015 Aug; 336(1):130-40. PubMed ID: 26112215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2.
    Xiao D; Li M; Herman-Antosiewicz A; Antosiewicz J; Xiao H; Lew KL; Zeng Y; Marynowski SW; Singh SV
    Nutr Cancer; 2006; 55(1):94-107. PubMed ID: 16965246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombospondin-1 is produced by retinal glial cells and inhibits the growth of vascular endothelial cells.
    Yafai Y; Eichler W; Iandiev I; Unterlauft JD; Jochmann C; Wiedemann P; Bringmann A
    Ophthalmic Res; 2014; 52(2):81-8. PubMed ID: 25138030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT; Chen NY; Franek KJ; Chen WY
    Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
    Etulain J; Mena HA; Negrotto S; Schattner M
    Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposite effects of endostatin on different endothelial cells.
    Schmidt A; Addicks K; Bloch W
    Cancer Biol Ther; 2004 Nov; 3(11):1162-6; discussion 1167-8. PubMed ID: 15640622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
    Taddei L; Chiarugi P; Brogelli L; Cirri P; Magnelli L; Raugei G; Ziche M; Granger HJ; Chiarugi V; Ramponi G
    Biochem Biophys Res Commun; 1999 Sep; 263(2):340-5. PubMed ID: 10491294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
    Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
    FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.
    Hamano Y; Sugimoto H; Soubasakos MA; Kieran M; Olsen BR; Lawler J; Sudhakar A; Kalluri R
    Cancer Res; 2004 Mar; 64(5):1570-4. PubMed ID: 14996710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.